Publications

Ortiz, C. S.; Montante-Montez, D.; Saqui-Salces, M.; Hinojosa, L. M.; Gamboa-Dominguez, A.; Hernández-Gallegos, E.; Martínez-Benítez, B.; Solís-Pancoatl, M. d. R.; Garcia-Villa, E.; Ramírez, A. et al.; Aguilar-Guadarrama, R.; Gariglio, P.; Pardo, L. A.; Stühmer, W.; Camacho, J.: Eag1 potassium channels as markers of cervical dysplasia. Oncology Reports 26 (6), pp. 1377 - 1383 (2011)

Kohl, T.; Lörinczi, E.; Pardo, L. A.; Stühmer, W.: Rapid internalization of the oncogenic K+ channel Kv10.1. PLoS ONE 6 (10), e26329 (2011)

Hartung, F.; Stühmer, W.; Pardo, L. A.: Tumor cell-selective apoptosis induction through targeting of KV10.1 via bifunctional TRAIL antibody. Molecular Cancer 10, 109 (2011)

Chen, Y.; Sánchez, A.; Rubio, M. E.; Kohl, T.; Pardo, L. A.; Stühmer, W.: Functional KV10.1 channels localize to the inner nuclear membrane. PLoS ONE 6 (5), e19257 (2011)

Grube, S.; Gerchen, M. F.; Adamcio, B.; Pardo, L. A.; Martin, S.; Malzahn, D.; Papiol, S.; Begemann, M.; Ribbe, K.; Friedrichs, H. et al.; Radyushkin, K. A.; Müller, M.; Benseler, F.; Riggert, J.; Falkai, P.; Bickeböller, H.; Nave, K.-A.; Brose, N.; Stühmer, W.; Ehrenreich, H.: A CAG repeat polymorphism of KCNN3 predicts SK3 channel function and cognitive performance in schizophrenia. Embo Molecular Medicine 3 (6), pp. 309 - 319 (2011)

Sausbier, U.; Dullin, C.; Misbach-Guentner, J.; Kabagema, C.; Flockerzie, K.; Kuscher, G. M.; Stuehmer, W.; Neuhuber, W.; Ruth, P.; Alves, F. et al.; Sausbier, M.: Osteopenia due to enhanced cathepsin K release by BK channel ablation in osteoclasts. PLoS ONE 6 (6), e21168 (2011)

Sussulini, A.; Dihazi, H.; Muller Banzato, C. E.; Zezzi Arruda, M. A.; Stühmer, W.; Ehrenreich, H.; Jahn, O.; Kratzin, H. D.: Apolipoprotein A-I as a candidate serum marker for the response to lithium treatment in bipolar disorder. Proteomics 11 (2), pp. 261 - 269 (2011)